A study published in Science Advances identifies a set of microproteins that are exclusively produced in liver tumors. This makes them a clear target for immune system cells and a potential target for...
Read moreResearchers from IDIBELL and ICO have developed a bioinformatics algorithm that will improve the diagnosis of two cancer predisposition syndromes.
Read moreA new study, published in the journal Metabolism, provides further evidence on the regulatory mechanisms of the liver enzyme glutaminase 1 (GLS) in metabolic liver disease, highlighting its role in am...
Read moreResearchers from Centre for Genomic Regulation (CRG) in Barcelona have each received a prestigious Proof of Concept (PoC) grant from the European Research Council in the first round of the 2024 compet...
Read moreA team led by scientists from Baylor College of Medicine, University of Copenhagen, and Centre Nacional d’Anàlisi Genòmica and Centre for Genomic Regulation report discovering fossils of ancient ...
Read moreTo help accelerate research into new treatments for Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS), Thermo Fisher Scientific Inc. is partnering with the National Cancer Institute (NCI...
Read moreLa Fundación FEDER, vinculada a la Federación Española de Enfermedades Raras, financia un proyecto de investigación liderado por el Dr. Francisco M. Vega y el Dr. Fernando Calvo Baltanás.
Read moreThe new method would allow for a more objective and precise classification of patients' types of osteoarthritis, supported by data mining techniques and biological modeling, which enable the analysis ...
Read moreUn estudio liderado por investigadoras del Instituto Catalán de Oncología (ICO) y el Instituto de Investigación Germans Trias i Pujol (IGTP) ha analizado muestras de sangre periférica de pacientes...
Read moreUn equipo de investigación de la Universidad de Sevilla ha diseñado una herramienta que identifica hasta siete tipos de enfermedades dermatológicas
Read moreCon este acuerdo, la biofarmacéutica española AbilityPharma inicia la fabricación de su fármaco principal ABTL0812 para administrar a pacientes con cáncer de páncreas en el marco del ensayo clí...
Read moreUn estudio promovido por SOLTI y publicado en Nature Communications describe la biología del tumor asociada a la actividad del fármaco patritumab deruxtecán, un anticuerpo conjugado a quimioterapia...
Read more